Neurofascin as a target for autoantibodies in peripheral neuropathies.
about
Neuroinflammation in the peripheral nerve: Cause, modulator, or bystander in peripheral neuropathies?Neuro-glial interactions at the nodes of Ranvier: implication in health and diseasesNode of Ranvier disruption as a cause of neurological diseasesMapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous systemNeurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.Postnatal Loss of Neuronal and Glial Neurofascins Differentially Affects Node of Ranvier Maintenance and Myelinated Axon Function.Endogenous antibodies contribute to macrophage-mediated demyelination in a mouse model for CMT1B.Contactin-1 and Neurofascin-155/-186 Are Not Targets of Auto-Antibodies in Multifocal Motor NeuropathyChronic inflammatory demyelinating polyneuropathy (CIDP): change of serum IgG dimer levels during treatment with intravenous immunoglobulins.Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype.Subtype-specific therapy for autoimmune neuropathies?Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy.Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.Neurofascin-155 as a putative antigen in combined central and peripheral demyelinationMaternal neurofascin-specific autoantibodies bind to structures of the fetal nervous system during pregnancy, but have no long term effect on development in the rat.An update in guillain-barré syndromeSpecific contactin N-glycans are implicated in neurofascin binding and autoimmune targeting in peripheral neuropathies.Animal models of autoimmune neuropathy.Long-term maintenance of Na+ channels at nodes of Ranvier depends on glial contact mediated by gliomedin and NrCAM.To look for a needle in a haystack: the search for autoantibodies in multiple sclerosis.Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.Optimizing IgG therapy in chronic autoimmune neuropathies: a hypothesis driven approach.Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders.Subcellular patterning: axonal domains with specialized structure and function.Fulminant Central Plus Peripheral Nervous System Demyelination without Antibodies to Neurofascin.The Nodes of Ranvier: Molecular Assembly and Maintenance.Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.Axonal domain disorganization in Caspr1 and Caspr2 mutant myelinated axons affects neuromuscular junction integrity, leading to muscle atrophy.Intravenous immunoglobulin: pharmacological properties and use in polyneuropathies.Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications.Inhibitory axons are targeted in hippocampal cell culture by anti-Caspr2 autoantibodies associated with limbic encephalitis.Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome.Diagnostic Utility of Auto Antibodies in Inflammatory Nerve Disorders.Differences in peripheral myelin antigen-specific T cell responses and T memory subsets in atypical versus typical CIDPThe paranodal cytoskeleton clusters Na+ channels at nodes of Ranvier.Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy.Disruption of nodal architecture in skin biopsies of patients with demyelinating neuropathies.Neurofascin (NF)155- and NF186-Specific T Cell Response in a Patient Developing a Central Pontocerebellar Demyelination after 10 Years of CIDP.Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies.
P2860
Q26801349-4E418097-26D2-459A-839D-475F86D127E6Q26825224-61066B4D-184D-4457-A696-6323627DCCEDQ27009974-DD50BDFD-A5F5-44E9-9299-DC6F54FA7C33Q28075974-07B9C30F-AAF8-499A-AF1C-174CA08FCAA3Q30574385-3EB73A6E-5566-438A-A1C4-7BCC6574127BQ30837291-84CB74D5-6ABB-4184-9F85-A3B7D8AC8084Q35191407-DCEBB340-30D6-4E7B-A4C2-6789F5F69DC7Q35719847-E1A53516-1483-4CB6-B23F-21B7FF72C9BDQ35950471-F12F3CEC-8EC3-42DC-ADC8-AB1F4509FE14Q36005389-A1E77F06-820C-4217-BABF-BA26CA8B1BE5Q36092674-FCFE97A5-8448-40FB-8630-BD301DDC1DFAQ36154796-A5EE92AB-A1F7-4BDF-A659-D5D978886EAFQ36691991-05CC0D7C-F4AF-42DA-B7D3-F224F389E162Q36981065-02045D1F-D127-4104-A2D6-9BBABA0ACC37Q37495741-BE7FE6B8-9B5C-44BC-94CC-CA3EFD49AC7CQ37544140-F833DAFA-90E8-409B-8BF7-9F3766D4C1EFQ37635865-294C310E-AD8D-44A3-A451-949D2D283645Q37655234-E72A2306-5078-4D7E-B0A6-D095DBC53BF6Q37698145-B6818A93-D2BC-44F7-9430-04BC4D21279EQ38192844-92897ACA-87FF-4002-9C12-95B0C06C0892Q38194642-53DEA20C-8E2D-43CC-AEBB-9C753CB897A1Q38270717-A54DD70B-163F-4FF9-BB47-9EC19AB7D409Q38333532-B6744B36-DFBB-4513-AB42-7BCE1BA25E79Q38364754-045C9690-A2DA-4A2B-8C7B-E3B70A8EB2A7Q38566269-C1BB8BC2-55D8-49AF-934E-EE08DDD0ACE1Q38583864-1B9BEB28-5843-4871-A5C8-B98C8786CB84Q38748481-83F12C75-6E4A-44CA-9BF2-94D0D95D567BQ38859584-FADCA03E-65A6-4EFA-809C-E822E7B8954FQ38900642-63C5CFBE-20F4-4152-8CA7-4F9C8D4FAF91Q39434973-C69DC5BE-D56D-404E-8536-0B5997D15311Q40688737-90102D16-450B-4043-BC86-B77D63375F56Q40994338-7447A4BB-3710-41CF-96F1-213631E6B2B3Q41189967-A38FB137-9349-4F92-9934-AE6A66CC0495Q42290388-37EE482C-0B85-4DC7-AB9F-A3AE26748232Q42326242-2CBCEEEA-9FBC-4EC2-BCA0-54F2248CBBA1Q43114504-79FC801A-494B-4B0E-9FA2-34790D585DB5Q43533051-BCACAD9B-82DF-4136-8CC3-2DF6750CEF59Q44424031-A6DACF1C-C63B-49D5-9175-9535821443AFQ47221782-91D0FFD7-ED1D-44B7-A3C2-AC8910D12DD3Q47327481-B98F8A18-300A-4172-8811-30EED97AA798
P2860
Neurofascin as a target for autoantibodies in peripheral neuropathies.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Neurofascin as a target for autoantibodies in peripheral neuropathies.
@ast
Neurofascin as a target for autoantibodies in peripheral neuropathies.
@en
type
label
Neurofascin as a target for autoantibodies in peripheral neuropathies.
@ast
Neurofascin as a target for autoantibodies in peripheral neuropathies.
@en
prefLabel
Neurofascin as a target for autoantibodies in peripheral neuropathies.
@ast
Neurofascin as a target for autoantibodies in peripheral neuropathies.
@en
P2093
P2860
P50
P1433
P1476
Neurofascin as a target for autoantibodies in peripheral neuropathies.
@en
P2093
Claudia Sommer
Edgar Meinl
Harald Prüss
Hendrik Harms
Joachim Malotka
Judy King Man Ng
Klaus Dornmair
Lutz Harms
Masaaki Odaka
Naoto Kawakami
P2860
P304
P356
10.1212/WNL.0B013E31827689AD
P407
P50
P577
2012-10-24T00:00:00Z